glp-1 receptor agonists weight loss for Management November Blog - What happens
Description
2024;54(12):e14292
For branded products approved to reduce weight in obesity, some also have expanded use to younger patients, and/or additional at-risk adult populations
(Menlo Park, CA)
After the initiation of GLP-1RA treatment, participants experienced WL between 3.6% and 17.6%
Andrikou E, Tsioufis C, Andrikou I, Leontsinis I, Tousoulis D, Papanas N
